When new medicines came to market in the 1990s and 2000s, they drastically changed the way people with HIV and AIDS were treated—often making the difference between life and death. HIV medications, including nucleoside reverse transcriptase inhibitors, or NRTIs, meant an HIV diagnosis didn’t have to be a death sentence and turned the virus into a manageable, chronic condition.
A new drug hit the market in 2004 that, in combination with NRTIs and other HIV medicines, could treat people who tested positive for HIV. The drug, Truvada PrEP with TDF, has since been approved to treat HIV-negative adults and protect them from contracting the virus and was recently approved to protect teens who test negative for HIV. When used as protection instead of treatment, it is called Truvada for pre-exposure prophylaxis, or PrEP.
Although Truvada with TDF has helped treat and protects many people from HIV infection, the drug has been potentially harmful to others. Like most HIV medicines, Truvada with TDF can put some people at an increased risk for serious kidney problems. For anyone seeking to take Truvada with TDF or other similar medications for HIV prevention or treatment, it is essential to understand all of the risks associated with the drugs to make an informed decision when talking with a healthcare provider.
Patients who started treatment using Truvada with TDF and subsequently developed severe health issues are beginning to file lawsuits against the drug, and its manufacturer, Gilead Sciences Inc. These lawsuits accuse Gilead Sciences of manufacturing a defective product and not informing the public of all the potential risks associated with the drug, among other allegations. If you took Truvada PrEP with TDF and developed severe kidney problems, you may qualify for a drug injury lawsuit and should file a claim today.